Frequency of multiple PIK3CA and PK3R1 concurrent mutations in endometrial cancers. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text ...
Comparison of clinical outcome between gefitinib and erlotinib treatment in patients with non-small cell lung cancer harboring an epidermal growth factor receptor exon 19 or exon 21 mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback